MHC matching fails to prevent long-term rejection of iPSC-derived neurons in non-human primates - Archive ouverte HAL Access content directly
Journal Articles Nature Communications Year : 2019

MHC matching fails to prevent long-term rejection of iPSC-derived neurons in non-human primates

(1, 2) , (3) , (1, 2) , (4) , (3) , (1, 2) , (5) , (1, 2) , (6) , (5, 4) , (1, 2) , (3)
1
2
3
4
5
6

Abstract

Cell therapy products (CTP) derived from pluripotent stem cells (iPSCs) may constitute a renewable, specifically differentiated source of cells to potentially cure patients with neurodegenerative disorders. However, the immunogenicity of CTP remains a major issue for therapeutic approaches based on transplantation of non-autologous stem cell-derived neural grafts. Despite its considerable side-effects, long-term immunosuppression, appears indispensable to mitigate neuro-inflammation and prevent rejection of allogeneic CTP. Matching iPSC donors' and patients' HLA haplotypes has been proposed as a way to access CTP with enhanced immunological compatibility, ultimately reducing the need for immunosuppression. In the present work, we challenge this paradigm by grafting autologous, MHC-matched and mis-matched neuronal grafts in a primate model of Huntington's disease. Unlike previous reports in unlesioned hosts, we show that in the absence of immunosuppression MHC matching alone is insufficient to grant long-term survival of neuronal grafts in the lesioned brain.
Fichier principal
Vignette du fichier
Aron-Badin et al_R3 NO MARK.PDF (1.32 Mo) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

cea-02997553 , version 1 (10-11-2020)

Identifiers

Cite

Romina Aron Badin, Aurore Bugi, Susannah Williams, Marta Vadori, Marie Michael, et al.. MHC matching fails to prevent long-term rejection of iPSC-derived neurons in non-human primates. Nature Communications, In press, 10, pp.4357. ⟨10.1038/s41467-019-12324-0⟩. ⟨cea-02997553⟩
120 View
66 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More